Literature DB >> 18628413

Colorectal cancer test use from the 2005 National Health Interview Survey.

Jean A Shapiro1, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Sally W Vernon.   

Abstract

BACKGROUND: Screening is effective in reducing colorectal cancer mortality. Recommended colorectal cancer screening options include a home fecal occult blood test (FOBT) or colorectal endoscopy (sigmoidoscopy or colonoscopy). Past surveys have indicated that colorectal cancer screening prevalence in the United States is low. The purpose of this analysis was to determine the prevalence of colorectal cancer test use in the United States by various factors and to examine reasons for not having a colorectal cancer test.
METHODS: Data on respondents ages > or =50 years from the 2005 National Health Interview Survey (n = 13,269) were analyzed. The proportion of the U.S. population that had home FOBT within the past year or endoscopy within the past 10 years was examined by sociodemographic, health-care access, and other health-related factors. Reported reasons for not having FOBT or endoscopy were also analyzed.
RESULTS: The age-standardized proportion of respondents who reported FOBT within the past year and/or endoscopy within the past 10 years was 50.0% [95% confidence interval (95% CI), 48.8-51.2]. Colorectal cancer testing rates were particularly low among people without health-care coverage (24.1%; 95% CI, 19.2-29.7) or without a usual source of health care (24.7%; 95% CI, 20.8-29.0). The most commonly reported reason for not having a colorectal cancer test was "never thought about it."
CONCLUSIONS: In 2005, about half of Americans ages > or =50 years did not have appropriate colorectal cancer testing. Increased efforts to expand health-care coverage or to provide colorectal cancer tests to people without health-care coverage are needed to increase colorectal cancer screening.

Entities:  

Mesh:

Year:  2008        PMID: 18628413     DOI: 10.1158/1055-9965.EPI-07-2838

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  116 in total

1.  Different effects of multiple health status indicators on breast and colorectal cancer screening in a nationally representative US sample.

Authors:  Anjali D Deshpande; Amy McQueen; Elliot J Coups
Journal:  Cancer Epidemiol       Date:  2011-11-11       Impact factor: 2.984

2.  A computerized intervention to promote colorectal cancer screening for underserved populations: theoretical background and algorithm development.

Authors:  K Allen Greiner; Mugur V Geana; Aaron Epp; Angela Watson; Melissa Filippi; Christine Makosky Daley; Kimberly K Engelman; Aimee S James; Marci Campbell
Journal:  Technol Health Care       Date:  2012       Impact factor: 1.285

3.  Distinguishing factors for asymptomatic colonoscopy screening.

Authors:  Corey H Basch; Charles E Basch; Randi L Wolf; Patricia Zybert
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

4.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

5.  Quality and safety of screening colonoscopies performed by primary care physicians with standby specialist support.

Authors:  Sudha Xirasagar; Thomas G Hurley; Lekhena Sros; James R Hebert
Journal:  Med Care       Date:  2010-08       Impact factor: 2.983

Review 6.  Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior.

Authors:  Marc T Kiviniemi; Alyssa Bennett; Marie Zaiter; James R Marshall
Journal:  Psychooncology       Date:  2010-10-27       Impact factor: 3.894

7.  Sex disparities in colorectal cancer incidence by anatomic subsite, race and age.

Authors:  Gwen Murphy; Susan S Devesa; Amanda J Cross; Peter D Inskip; Katherine A McGlynn; Michael B Cook
Journal:  Int J Cancer       Date:  2010-05-25       Impact factor: 7.396

8.  Cancer control needs of 2-1-1 callers in Missouri, North Carolina, Texas, and Washington.

Authors:  Jason Q Purnell; Matthew W Kreuter; Katherine S Eddens; Kurt M Ribisl; Peggy Hannon; Rebecca S Williams; Maria E Fernandez; David Jobe; Susan Gemmel; Marti Morris; Debbie Fagin
Journal:  J Health Care Poor Underserved       Date:  2012-05

9.  Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.

Authors:  Chyke A Doubeni; Adeyinka O Laiyemo; Angela C Young; Carrie N Klabunde; George Reed; Terry S Field; Robert H Fletcher
Journal:  Ann Fam Med       Date:  2010 Jul-Aug       Impact factor: 5.166

10.  Screening rates for colorectal cancer in Canada: a cross-sectional study.

Authors:  Harminder Singh; Charles N Bernstein; Jewel N Samadder; Rashid Ahmed
Journal:  CMAJ Open       Date:  2015-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.